Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-04

Clinical Trial Update: Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 Diabetes [NA]

View source ↗

Summary

This clinical trial update evaluates dorzagliatin for its effects on insulin and incretin function in individuals with intermediate hyperglycemia and type 2 dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dorzagliatin (dorzagliatin)

Snippet

Sponsor: Elaine Chow | Conditions: Diabetes Mellitus, Prediabetes / Type 2 Diabetes | NA | Status: NOT_YET_RECRUITING